Savara
SVRA
#5977
Rank
$1.16 B
Marketcap
$5.66
Share price
-2.99%
Change (1 day)
147.38%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -$0.13 Billion USD

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$0.12 Billion USD a decrease over its 2024 earnings that were of -$95.89 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.13 Billion8.96%
2025 -$0.12 Billion23.94%
2024 -$95.89 Million75.29%
2023 -$54.7 Million43.38%
2022 -$38.15 Million-11.31%
2021 -$43.02 Million-13.3%
2020 -$49.62 Million-36.53%
2019 -$78.18 Million13.76%
2018 -$68.72 Million105.54%
2017 -$33.44 Million34.11%
2016 -$24.93 Million-37.43%
2015 -$39.85 Million38.81%
2014 -$28.71 Million33.62%
2013 -$21.49 Million38.49%
2012 -$15.52 Million24.59%
2011 -$12.45 Million-36.5%
2010 -$19.61 Million-3.14%
2009 -$20.25 Million-23.28%
2008 -$26.39 Million8.52%
2007 -$24.32 Million-34.14%
2006 -$36.92 Million184.43%
2005 -$12.98 Million90.75%
2004 -$6.81 Million190.35%
2003 -$2.35 Million11.64%
2002 -$2.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-$0.23 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$18.16 Million-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA